Soleno Therapeutics (SLNO) Revenue: 2013-2017
Historic Revenue for Soleno Therapeutics (SLNO) over the last 3 years, with Jun 2017 value amounting to $1,000.
- Soleno Therapeutics' Revenue fell 50.00% to $1,000 in Q2 2017 from the same period last year, while for Jun 2017 it was $878,788, marking a year-over-year decrease of 6.26%. This contributed to the annual value of -$231,000 for FY2024, which is N/A change from last year.
- Latest data reveals that Soleno Therapeutics reported Revenue of $1,000 as of Q2 2017, which was down 99.62% from $265,000 recorded in Q1 2017.
- In the past 5 years, Soleno Therapeutics' Revenue registered a high of $447,000 during Q1 2016, and its lowest value of -$2.3 million during Q4 2014.
- Over the past 3 years, Soleno Therapeutics' median Revenue value was $244,236 (recorded in 2015), while the average stood at $193,526.
- Per our database at Business Quant, Soleno Therapeutics' Revenue crashed by 647.87% in 2014 and then soared by 1,931.82% in 2016.
- Quarterly analysis of 5 years shows Soleno Therapeutics' Revenue stood at -$310,267 in 2013, then slumped by 647.87% to -$2.3 million in 2014, then surged by 110.41% to $241,472 in 2015, then rose by 17.52% to $283,788 in 2016, then crashed by 50.00% to $1,000 in 2017.
- Its last three reported values are $1,000 in Q2 2017, $265,000 for Q1 2017, and $283,788 during Q4 2016.